SuperworthFortrea market cap FTRE
Share price times shares outstanding: what the whole company sells for, since 2023.
- Today, Oct 23, 2026
- $2.2B
- Highest close in our data
- $3.6B
- Mar 2024
Fortrea is worth $2.2B at the close on Oct 23, 2026, at $23.63 a share.
That is up 119% over the last year.
Its highest close in our data was $3.6B in Mar 2024.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $2.2B | $835M | $2.2B | +40% |
| 2025 | $1.6B | $367.4M | $1.7B | −7% |
| 2024 | $1.7B | $1.5B | $3.6B | −44% |
| 2023 | $3.1B | $2.3B | $3.1B | n/a |
Against its peers
Companies in Medical - Diagnostics & Research nearest Fortrea's size, closest first, today.
| Company | Market cap |
|---|---|
| FTREFortrea | $2.2B |
| CDNACareDx | $3.6B |
| VCYTVeracyte | $3.9B |
| BLLNBillionToOne | $5.1B |
| LNTHLantheus | $6.5B |
| CAICaris Life Sciences | $9B |
| BIOBio-Rad Laboratories | $9.9B |
| NRCNRC Health | $485.1M |
| RVTYRevvity | $17.7B |
| MEDPMedpace | $18.7B |
| Peer median | $6.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Fortrea
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.